SEC Form 5 · accession 0001144204-18-000204
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur Przybyl
Officer — President & CEO · Director
Period of report
Dec 31, 2017
Accepted (ET)
Jan 2, 2018 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 20, 2017 | G | 850 | $0.00 | D | 209,983 | D |
Table II — derivative securities
No Table II lines on this filing.